AAM
CYTK icon

AMI Asset Management’s Cytokinetics CYTK Stock Holding History

AMI Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
14,261
-555
-4% -$39.9K 0.07% 45
2026
Q1 		$977K Buy
14,816
+536
+4% +$34.1K 0.06% 57
2025
Q4 		$907K Sell
14,280
-1,003
-7% -$62.4K 0.05% 62
2025
Q3 		$840K Buy
+15,283
New +$630K 0.05% 67

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AMI Asset Management's CYTK Position: Q2 2026 in Review

AMI Asset Management reduced its Cytokinetics (CYTK) stake by 3.7% in Q2 2026, selling an estimated $39.9K and leaving 14,261 shares worth $1.21M. The position accounts for 0.07% of the portfolio, ranked #45.

AMI Asset Management first reported a position in CYTK in Q3 2025 and has held it in 4 quarters since. 483 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • AMI Asset Management held 14,261 shares of Cytokinetics worth $1.21M as of Q2 2026.
  • AMI Asset Management sold 555 Cytokinetics shares in Q2 2026, an estimated $39.9K.
  • Cytokinetics made up 0.07% of AMI Asset Management's portfolio in Q2 2026, its #45 holding.
  • AMI Asset Management first reported a position in Cytokinetics in Q3 2025 and has held it in 4 quarters since.
  • 483 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on AMI Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.